机构：[1]Department of Oncology. Guangdong TCM-Integrated Hospital. Foshan. China.[2]Department of Oncology. Wuyi Hospital of Traditional Chinese medicine. Jiangmen . China.[3]Department of Intervention. The First Affiliated Hospital of Guangzhou Medical University. Guangzhou. China.[4]Department of Oncology. Gaoming People's Hospital. Gaoming. China.
This study aimed to investigate the clinical efficacy and feasibility of the treatment of advanced esophageal cancer with a combination of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen.
45 patients with advanced esophageal cancer were enrolled and were randomly divided into two groups: a treatment group and a control group. Patients in the treatment group were treated with a 125I particle-integrated esophageal covered stent and hyperbaric oxygen, while patients in the control group were treated with a 125I particle-integrated esophageal covered stent, and the clinical effects and long-term survival time of the two groups were observed.
In the treatment group, the complete remission (CR) rate and partial remission (PR) rate of local lesions were 19.2% and 61.5% respectively, and the total effective rate was 80.7%. In the control group, the CR rate and PR rate of local lesions were 10.5% and 52.6%, respectively, and the total effective rate was 63.1%. The total effective rate was higher in the treatment group than in the control group, and the difference was statistically significant (P < 0.05).
The combination of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen shows good short- and long-term efficacy in the treatment of advanced esophageal cancer.
基金：
This study was funded by the Project of Foshan Science and Technology Bureau, Project
Number: 2018AB000102.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|4 区医学
小类|4 区胃肠肝病学
最新[2025]版：
大类|4 区医学
小类|4 区胃肠肝病学
第一作者：
第一作者机构：[1]Department of Oncology. Guangdong TCM-Integrated Hospital. Foshan. China.[*1]Department of Oncology, Guangdong TCM-Integrated Hospital, No. 16 of South Fifth Road, Guicheng, Nanhai District, Foshan 528200, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Oncology. Guangdong TCM-Integrated Hospital. Foshan. China.[*1]Department of Oncology, Guangdong TCM-Integrated Hospital, No. 16 of South Fifth Road, Guicheng, Nanhai District, Foshan 528200, China
推荐引用方式(GB/T 7714)：
Qi-zhou Zhang,Guo-liang Li,Jian-biao Shang,et al.Clinical study of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen in the treatment of advanced esophageal cancer.[J].Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.2021,113(8):576-579.doi:10.17235/reed.2020.7377/2020.
APA：
Qi-zhou Zhang,Guo-liang Li,Jian-biao Shang,Yi-min Ren&Jian-li Xie.(2021).Clinical study of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen in the treatment of advanced esophageal cancer..Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva,113,(8)
MLA：
Qi-zhou Zhang,et al."Clinical study of a 125I particle-integrated esophageal covered stent and hyperbaric oxygen in the treatment of advanced esophageal cancer.".Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 113..8(2021):576-579
